Conditional expression of murine Flt3 ligand leads to expansion of multiple dendritic cell subsets in peripheral blood and tissues of transgenic mice

Journal of Immunology

Volumn 170, Issue 6, 2003, Pages 2843-2852

  Manfra, Denise J ^a   Chen, Shu Cheng ^a   Jensen, Kristian K ^a   Fine, Jay S ^a   Wiekowski, Maria T ^a   Lira, Sergio A ^a,b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD8 ANTIGEN; DOXYCYCLINE; FLT3 LIGAND; GLYCOPROTEIN P 15095; GREEN FLUORESCENT PROTEIN; HEMOPOIETIC GROWTH FACTOR; TETRACYCLINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MOTILITY; CELL SUBPOPULATION; CONTROLLED STUDY; DENDRITIC CELL; HOMEOSTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0037443489     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.6.2843     Document Type: Article

References (41)

1. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.
2. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693.
3. Lyman, S. D. 1998. Biologic effects and potential clinical applications of Flt3 ligand. Curr Opin Hematol 5:192.
4. Lyman, S. D., and S. E. Jacobsen. 1999. c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood 91:1101.
5. Shurin, M. R., P. P. Pandharipande, T. D. Zorina, C. Haluszczak, V. M. Subbotin, O. Hunter, A. Brumfield, W. J. Storkus, E. Maraskovsky, and M. T. Lotze. 1997. FLT3 ligand induces the generation of functionally active dendritic cells in mice. Cell. Immunol. 179:174.
6. Banu, N., B. Deng, S. D. Lyman, and H. Avraham. 1999. Modulation of haematopoietic progenitor development by FLT-3 ligand. Cytokine 11:679.
7. Maraskovsky, E., E. Daro, E. Roux, M. Teepe, C. R. Maliszewski, J. Hoek, D. Caron, M. E. Lebsack, and H. J. McKenna. 2000. In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood 96:878.
8. Brasel, K., S. Escobar, R. Anderberg, P. de Vries, H. J. Gruss, and S. D. Lyman. 1995. Expression of the flt3 receptor and its ligand on hematopoietic cells. Leukemia 9:1212.
9. Brasel, K., H. J. McKenna, P. J. Morrissey, K. Charrier, A. E. Morris, C. C. Lee, D. E. Williams, and S. D. Lyman. 1996. Hematologic effects of flt3 ligand in vivo in mice. Blood 88:2004.
10. Maraskovsky, E., K. Brasel, M. Teepe, E. R. Roux, S. D. Lyman, K. Shortman, and H. J. McKenna. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184:1953.
11. Pulendran, B., J. Lingappa, M. K. Kennedy, J. Smith, M. Teepe, A. Rudensky, C. R. Maliszewski, and E. Maraskovsky. 1997. Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J. Immunol. 159:2222.
12. + lymphoid-related dendritic cells. J. Immunol. 165:795.
13. Hannum, C., J. Culpepper, D. Campbell, T. McClanahan, S. Zurawski, J. F. Bazan, R. Kastelein, S. Hudak, J. Wagner, J. Mattson, et al. 1994. Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 368:643.
14. Lyman, S. D., L. James, T. Vanden Bos, P. de Vries, K. Brasel, B. Gliniak, L. T. Hollingsworth, K. S. Picha, H. J. McKenna, R. R. Splett, et al. 1993. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell 75:1157.
15. Lyman, S. D., K. Stocking, B. Davison, F. Fletcher, L. Johnson, and S. Escobar. 1995. Structural analysis of human and murine flt3 ligand genomic loci. Oncogene 11:1165.
16. McClanahan, T., J. Culpepper, D. Campbell, J. Wagner, K. Franz-Bacon, J. Mattson, S. Tsai, J. Luh, M. J. Guimaraes, M. G. Mattei, et al. 1996. Biochemical and genetic characterization of multiple splice variants of the Flt3 ligand. Blood 88:3371.
17. Niwa, H., K. Yamamura, and J. Miyazaki. 1991. Efficient selection for highexpression transfectants with a novel eukaryofic vector. Gene 108:193.
18. Mann, J. R., and A. P. McMahon. 1993. Factors influencing production frequency of transgenic mice. Methods Enzymol. 225:771.
19. Wiekowski, M. T., S. C. Chen, P. Zalamea, B. P. Wilburn, D. J. Kinsley, W. W. Sharif, K. K. Jensen, J. A. Hedrick, D. Manfra, and S. A. Lira. 2001. Disruption of neutrophil migration in a conditional transgenic model: evidence for CXCR2 desensitization in vivo. J. Immunol. 167:7102.
20. Hogan, B., R. Beddington, F. Costantini, and E. Lacy. 1994. Manipulation of the mouse embryo. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
21. Lira, S. 1999. Lessons from gene modified mice. Forum 9:286.
22. Manfra, D. J., S. C. Chen, T. Y. Yang, L. Sullivan, M. T. Wiekowski, S. Abbondanzo, G. Vassileva, P. Zalamea, D. N. Cook, and S. A. Lira. 2001. Leukocytes expressing green fluorescent protein as novel reagents for adoptive cell transfer and bone marrow transplantation studies. Am. J. Pathol. 158:41.
23. Soares, H. D., S. C. Chen, and J. I. Morgan. 2001. Differential and prolonged expression of Fos-lacZ and Jun-lacZ in neurons, glia, and muscle following sciatic nerve damage. Exp. Neurol. 167:1.
24. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547.
25. Imai, E., Y. Akagi, Y. Isaka, M. Ikawa, M. Takenaka, M. Hori, and M. Okabe. 1999. Glowing podocytes in living mouse: transgenic mouse carrying a podocytespecific promoter. Exp. Nephrol. 7:63.
26. Siegal, F. P., N. Kadowaki, M. Shodell, P. A. Fitzgerald-Bocarsly, K. Shah, S. Ho, S. Antonenko, and Y. J. Liu. 1999. The nature of the principal type 1 interferon-producing cells in human blood. Science 284:1835.
27. Cella, M., F. Facchetti, A. Lanzavecchia, and M. Colonna. 2000. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat. Immunol. 1:305.
28. Asselin-Paturel, C., A. Boonstra, M. Dalod, I. Durand, N. Yessaad, C. Dezutter-Dambuyant, A. Vicari, A. O'Garra, C. Biron, F. Briere, et al. 2001. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2:1144.
29. + cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 194:1171.
30. Liu, Y. J. 2001. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106:259.
31. Antonysamy, M. A., and A. W. Thomson. 2000. Flt3 ligand (FL) and its influence on immune reactivity. Cytokine 12:87.
32. Shaw, S. G., A. A. Maung, R. J. Steptoe, A. W. Thomson, and N. L. Vujanovic. 1998. Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-1igand: implications for anti-cancer and anti-viral therapy. J. Immunol. 161:2817.
33. Juan, T. S., I. K. McNiece, G. Van, D. Lacey, C. Hartley, P. McElroy, Y. Sun, J. Argento, D. Hill, X. Q. Yan, et al. 1997. Chronic expression of murine flt3 ligand in mice results in increased circulating white blood cell levels and abnormal cellular infiltrates associated with splenic fibrosis. Blood 90:76.
34. Biron, C. A. 1998. Role of early cytokines, including α and β interferons (IFN-α/β), in innate and adaptive immune responses to viral infections. Semin. Immunol. 10:383.
35. Pfeffer, L. M., C. A. Dinarello, R. B. Herberman, B. R. Williams, E. C. Borden, R. Bordens, M. R. Walter, T. L. Nagabhushan, P. P. Trotta, and S. Pestka. 1998. Biological properties of recombinant α-interferons: 40th anniversary of the discovery of interferons. Cancer Res. 58:2489.
36. Gilliet, M., A. Boonstra, C. Paturel, S. Antonenko, X. L. Xu, G. Trinchieri, A. O'Garra, and Y. J. Liu. 2002. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 195:953.
37. Caux, C., S. Ait-Yahia, K. Chemin, O. de Bouteiller, M. C. Dieu-Nosjean, B. Homey, C. Massacrier, B. Vanbervliet, A. Zlotnik, and A. Vicari. 2000. Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin. Immunopathol. 22:345.
38. Niederlova, J., and K. Koubek. 1999. Chemokines and chemokine receptors (review article). Sb. Lek. 100:169.
39. Yoshie, O. 2000. Role of chemokines in trafficking of lymphocytes and dendritic ceils. Int. J. Hematol. 72:399.
40. Cook, D. N., D. M. Prosser, R. Forster, J. Zhang, N. A. Kuklin, S. J. Abbondanzo, X. D. Niu, S. C. Chen, D. J. Manfra, M. T. Wiekowski, et al. 2000. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 12:495.
41. Forster, R., A. Schubel, D. Breitfeld, E. Kremmer, I. Renner-Muller, E. Wolf, and M. Lipp. 1999. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99:23.